Effect of Vitamin-D as an Adjuvant to Phototherapy in Reduction of Indirect Serum Bilirubin

NACompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Hyperbilirubinemia
Interventions
DRUG

Vitamin D3

Neonates were given vitamin D3 (cholecalciferol) in an oral drops formulation (400 IU/drop), at a dose of 400 IU once a day until the serum bilirubin level was out of phototherapy range or a maximum of 72 hours as an adjuvant therapy to phototherapy.

PROCEDURE

Phototherapy

Neonates received only phototherapy until the serum bilirubin level was out of phototherapy range or a maximum of 72 hours.

Trial Locations (1)

54000

Mayo Hospital, Lahore

All Listed Sponsors
lead

Muhammad Aamir Latif

OTHER